Ultraschallgeführte lokalablative Verfahren zur Behandlung von Schilddrüsenläsionen

Zusammenfassung

Ultraschallgeführte lokalablative Verfahren kommen als Ergänzung zur chirurgischen Therapie und Radiojodtherapie zunehmend in der Routinebehandlung von Schilddrüsenknoten zur Anwendung. Bei rein zystischen und überwiegend zystischen Herdbefunden liegen gute Erfahrungen mit der Instillationstherapie (Ethanol-/Polidocanol-Ablation) vor. Die neueren thermoablativen Techniken, zu denen die Radiofrequenzablation (RFA), die Mikrowellenablation (MWA), die Laserablation (LA) und der hochintensive fokussierte Ultraschall (HIFU) zählen, erreichen mittels Temperaturen von über 60 °C eine lokale Proteindenaturierung im Zielareal. Unter permanenter Ultraschallkontrolle kann so selektiv die Volumenreduktion lokal symptomatischer oder fokal hyperfunktioneller Befunde zur Erlangung von Beschwerdefreiheit induziert werden. Während bereits vielfältige Evidenz für die effektive und sichere Anwendung verschiedener lokalablativer Techniken geschaffen werden konnte, liegen künftige Herausforderungen in der Initiierung komparativer prospektiver Studien sowie standardisierter Curricula zur Schulung und kontinuierlichen Qualitätssicherung. Ferner wird es zukünftig angezeigt sein, die in Deutschland bei Patienten mitunter noch wenig bekannten lokalablativen Techniken im Aufklärungsgespräch als etablierte Alternative oder Ergänzung zu bestehenden Therapieformen anzuführen.

Abstract

Ultrasound-guided ablation techniques have been increasingly introduced into routine treatment of thyroid lesions as a complement to existing surgical therapies and radioiodine treatment. In cystic or predominantly cystic lesions instillation therapy (ethanol/polidocanol ablation) has yielded good results. Novel thermal ablation techniques, including radiofrequency ablation (RFA), microwave ablation (MWA), laser ablation (LA) and high intensity focused ultrasound (HIFU), induce irreversible cellular effects by locally applying temperatures ≥ 60 °C to the targeted thyroid region. Lesions causing local symptoms or focal hyperfunctionality can thus be selectively treated under continuous sonographic monitoring. While a considerable body of evidence supports the efficacy and safety of various local ablative techniques, future challenges lie in initiating comparative prospective trials and in standardizing clinical practice, training and continuous quality assessment on a regional and superregional level. In the future, it shall be indicated to include local ablative techniques – so far not known to all patients in Germany – into the informed decision-making process as a suitable alternative or supplement to existing therapies.

Schlüsselwörter

Schilddrüsenknoten - tomografischer Ultraschall - Thermoablation - Radiofrequenzablation - Ethanolablation

Keywords

thyroid nodule - tomographic ultrasound - thermal ablation - radiofrequency ablation - ethanol ablation

Publication History

Article published online:
21 September 2023

• Literatur

• 1 Völzke H, Lüdemann J, Robinson DM. et al. The Prevalence of Undiagnosed Thyroid Disorders in a Previously Iodine-Deficient Area. Thyroid 2003; 13: 803-810 DOI: 10.1089/105072503768499680. (PMID: 14558922)
• 2 Reiners C, Wegscheider K, Schicha H. et al. Prevalence of Thyroid Disorders in the Working Population of Germany: Ultrasonography Screening in 96,278 Unselected Employees. Thyroid 2004; 14: 926-932 DOI: 10.1089/thy.2004.14.926. (PMID: 15671771)
• 3 Papini E, Monpeyssen H, Frasoldati A. et al. 2020 European Thyroid Association Clinical Practice Guideline for the Use of Image-Guided Ablation in Benign Thyroid Nodules. European Thyroid J 2020; 9: 169-182 DOI: 10.1159/000508484. (PMID: 32903999)
• 4 Dobnig H, Zechmann W, Hermann M. et al. Radiofrequency ablation of thyroid nodules: “Good Clinical Practice Recommendations” for Austria. Wien Med Wochenschr 2019; 1-9 DOI: 10.1007/s10354-019-0682-2.
• 5 Kim J, Baek JH, Lim HK. et al. 2017 Thyroid Radiofrequency Ablation Guideline: Korean Society of Thyroid Radiology. Korean J Radiol 2018; 19: 632-655 DOI: 10.3348/kjr.2018.19.4.632. (PMID: 29962870)
• 6 Feldkamp J, Grünwald F, Luster M. et al. Non-Surgical and Non-Radioiodine Techniques for Ablation of Benign Thyroid Nodules: Consensus Statement and Recommendation*. Exp Clin Endocr Diab 2020; DOI: 10.1055/a-1075-2025.
• 7 Papini E, Pacella CM, Solbiati LA. et al. Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group. Int J Hyperther 2019; 1-7 DOI: 10.1080/02656736.2019.1575482.
• 8 Orloff LA, Noel JE, Stack BC. et al. Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease: An international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery, Associazione Medici Endocrinologi, British Association of Endocrine and Thyroid Surgeons, European Thyroid Association, Italian Society of Endocrine Surgery Units, Korean Society of Thyroid Radiology, Latin American Thyroid Society, and Thyroid Nodules Therapies Association. Head Neck 2022; 44: 633-660 DOI: 10.1002/hed.26960.
• 9 Livraghi T, Paracchi A, Ferrari C. et al. Treatment of autonomous thyroid nodules with percutaneous ethanol injection: preliminary results. Work in progress. Radiology 1990; 175: 827-829 DOI: 10.1148/radiology.175.3.2188302.
• 10 Bennedbæk FN, Hegedüs L. Treatment of Recurrent Thyroid Cysts with Ethanol: A Randomized Double-Blind Controlled Trial. J Clin Endocrinol Metabolism 2003; 88: 5773-5777 DOI: 10.1210/jc.2003-031000.
• 11 Yang CC, Hsu Y, Liou JY. Efficacy of Ethanol Ablation for Benign Thyroid Cysts and Predominantly Cystic Nodules: A Systematic Review and Meta-Analysis. Endocrinol Metab 2021; 36: 81-95 DOI: 10.3803/enm.2020.833. (PMID: 33677930)
• 12 Gong X, Wang F, Du H. et al. Comparison of Ultrasound-Guided Percutaneous Polidocanol Injection Versus Percutaneous Ethanol Injection for Treatment of Benign Cystic Thyroid Nodules. J Ultras Med 2018; 37: 1423-1429 DOI: 10.1002/jum.14482. (PMID: 29219197)
• 13 Gong X, Zhou Q, Wang F. et al. Efficacy and Safety of Ultrasound-Guided Percutaneous Polidocanol Sclerotherapy in Benign Cystic Thyroid Nodules: Preliminary Results. Int J Endocrinol 2017; 2017: 8043429 DOI: 10.1155/2017/8043429. (PMID: 28642791)
• 14 Kim YS, Rhim H, Tae K. et al. Radiofrequency Ablation of Benign Cold Thyroid Nodules: Initial Clinical Experience. Thyroid 2006; 16: 361-367 DOI: 10.1089/thy.2006.16.361. (PMID: 16646682)
• 15 Dobnig H, Amrein K. Monopolar radiofrequency ablation of thyroid nodules: a prospective Austrian single center study. Thyroid 2018; DOI: 10.1089/thy.2017.0547.
• 16 Deandrea M, Trimboli P, Garino F. et al. Long-Term Efficacy of a Single Session of RFA for Benign Thyroid Nodules: A Longitudinal 5-Year Observational Study. J Clin Endocrinol Metabolism 2019; 104: 3751-3756 DOI: 10.1210/jc.2018-02808. (PMID: 30860579)
• 17 Korkusuz H, Happel C, Grünwald F. Ultrasound guided percutaneous microwave ablation of hypofunctional thyroid nodules: evaluation by scintigraphic 99mTc-MIBI imaging. Nuklearmedizin Nucl Medicine 2013; 52: N68
• 18 Yue W, Wang S, Wang B. et al. Ultrasound guided percutaneous microwave ablation of benign thyroid nodules: Safety and imaging follow-up in 222 patients. Eur J Radiol 2013; 82: e11-e16 DOI: 10.1016/j.ejrad.2012.07.020. (PMID: 22940229)
• 19 Zhao J, Qian L, Liu Y. et al. A long-term retrospective study of ultrasound-guided microwave ablation of thyroid benign solid nodules. Int J Hyperther 2021; 38: 1566-1570 DOI: 10.1080/02656736.2021.1994659. (PMID: 34727816)
• 20 Døssing H, Bennedbæk FN, Karstrup S. et al. Benign Solitary Solid Cold Thyroid Nodules: US-guided Interstitial Laser Photocoagulation – Initial Experience. Radiology 2002; 225: 53-57 DOI: 10.1148/radiol.2251011042. (PMID: 12354983)
• 21 Gambelunghe G, Stefanetti E, Avenia N. et al. Percutaneous, Ultrasound-guided Laser Ablation of Benign Thyroid Nodules: Results of 10-year Follow-up in 171 Patients. J Endocr Soc 2021; 5: bvab081 DOI: 10.1210/jendso/bvab081. (PMID: 34159286)
• 22 Squarcia M, Mora M, Aranda G. et al. Long-Term Follow-Up of Single-Fiber Multiple Low-Intensity Energy Laser Ablation Technique of Benign Thyroid Nodules. Frontiers Oncol 2021; 11: 584265 DOI: 10.3389/fonc.2021.584265. (PMID: 34950572)
• 23 Lang BHH, Woo YC, Chiu KWH. Evaluation of pain during high-intensity focused ultrasound ablation of benign thyroid nodules. Eur Radiol 2018; 28: 2620-2627 DOI: 10.1007/s00330-017-5200-6. (PMID: 29330630)
• 24 Lang BHH, Woo YC, Wong CKH. High-Intensity Focused Ultrasound for Treatment of Symptomatic Benign Thyroid Nodules: A Prospective Study. Radiology 2017; 284: 897-906 DOI: 10.1148/radiol.2017161640. (PMID: 28419814)
• 25 Lang BHH, Woo YC, Chiu KWH. Two-year efficacy of single-session high-intensity focused ultrasound (HIFU) ablation of benign thyroid nodules. Eur Radiol 2019; 29: 93-101 DOI: 10.1007/s00330-018-5579-8. (PMID: 29922925)
• 26 Tessler FN, Middleton WD, Grant EG. Thyroid Imaging Reporting and Data System (TI-RADS): A User’s Guide. Radiology 2018; 287: 29-36 DOI: 10.1148/radiol.2017171240. (PMID: 29558300)
• 27 Russ G, Bonnema SJ, Erdogan MF. et al. European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS. European Thyroid J 2017; 6: 225-237 DOI: 10.1159/000478927. (PMID: 29167761)
• 28 Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid 2017; 27: 1341-1346 DOI: 10.1089/thy.2017.0500. (PMID: 29091573)
• 29 Schenke S, Zimny M, Rink T. et al. 99mTc-MIBI-Szintigraphie hypofunktioneller Schilddrüsenknoten. Nuklearmed 2014; 53: 105-110 DOI: 10.3413/nukmed-0619-13-08.
• 30 Hahn SY, Shin JH, Na DG. et al. Ethanol Ablation of the Thyroid Nodules: 2018 Consensus Statement by the Korean Society of Thyroid Radiology. Korean J Radiol 2019; 20 DOI: 10.3348/kjr.2018.0696. (PMID: 30887743)
• 31 Suh CH, Baek JH, Ha EJ. et al. Ethanol ablation of predominantly cystic thyroid nodules: Evaluation of recurrence rate and factors related to recurrence. Clin Radiol 2015; 70: 42-47 DOI: 10.1016/j.crad.2014.09.008. (PMID: 25443776)
• 32 Park HS, Yim Y, Baek JH. et al. Ethanol ablation as a treatment strategy for benign cystic thyroid nodules: a comparison of the ethanol retention and aspiration techniques. Ultrasonography 2019; 38: 166-171 DOI: 10.14366/usg.18033. (PMID: 30317854)
• 33 Kim YJ, Baek JH, Ha EJ. et al. Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors. Eur Radiol 2012; 22: 1573-1578 DOI: 10.1007/s00330-012-2406-5. (PMID: 22437920)
• 34 Maher DI, Goare S, Forrest E. et al. Routine Preoperative Laryngoscopy for Thyroid Surgery Is Not Necessary Without Risk Factors. Thyroid 2019; 29: 1646-1652 DOI: 10.1089/thy.2019.0145.
• 35 Donaldson M, Gizzarelli G, Chanpong B. Oral Sedation: A Primer on Anxiolysis for the Adult Patient. Anesthesia Prog 2007; 54: 118-129 DOI: 10.2344/0003-3006(2007)54[118:osapoa]2.0.co;2. (PMID: 17900211)
• 36 Dossa F, Dubé C, Tinmouth J. et al. Practice recommendations for the use of sedation in routine hospital-based colonoscopy. Bmj Open Gastroenterology 2020; 7: e000348 DOI: 10.1136/bmjgast-2019-000348. (PMID: 32128226)
• 37 Krönke M, Eilers C, Dimova D. et al. Tracked 3D ultrasound and deep neural network-based thyroid segmentation reduce interobserver variability in thyroid volumetry. Plos One 2022; 17: e0268550 DOI: 10.1371/journal.pone.0268550. (PMID: 35905038)
• 38 Kohlhase KD, Korkusuz Y, Gröner D. et al. Bipolar radiofrequency ablation of benign thyroid nodules using a multiple overlapping shot technique in a 3-month follow-up. Int J Hyperther 2016; 32: 1-6 DOI: 10.3109/02656736.2016.1149234. (PMID: 27126512)
• 39 Sim JS, Baek JH, Lee J. et al. Radiofrequency ablation of benign thyroid nodules: depicting early sign of regrowth by calculating vital volume. Int J Hyperther 2017; 33: 1-17 DOI: 10.1080/02656736.2017.1309083. (PMID: 28540795)
• 40 Xiaoyin T, Ping L, Dan C. et al. Risk Assessment and Hydrodissection Technique for Radiofrequency Ablation of Thyroid Benign Nodules. J Cancer 2018; 9: 3058-3066 DOI: 10.7150/jca.26060. (PMID: 30210628)
• 41 Baek JH, Lee JH, Sung JY. et al. Complications Encountered in the Treatment of Benign Thyroid Nodules with US-guided Radiofrequency Ablation: A Multicenter Study. Radiology 2012; 262: 335-342 DOI: 10.1148/radiol.11110416.
• 42 Dobnig H, Zechmann W, Hermann M. et al. Radiofrequenzablation von Schilddrüsenknoten: Good Clinical Practice Empfehlungen. J Für Klinische Endokrinologie Und Stoffwechsel 2018; 11: 73-80 DOI: 10.1007/s41969-018-0043-6.